Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (111-120 of 208) with videos related to

Pageof 21
Sort By:
BJU International|January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomyXavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
Journal of the National Cancer Institute|December 22, 2010
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionCéline Vallot, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
The Prostate|April 26, 2006
Protocadherin-PC promotes androgen-independent prostate cancer cell growthStephane Terry, Luis Queires, Sixtina Gil-Diez-de-Medina, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
BJU International|December 3, 2022
A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancerYann Neuzillet, Priscilla Leon, Thomas Seisen, et al.
Urology|November 16, 2005
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcomeMark A Rubin, Yves Allory, Vincent Molinié, et al.
Histopathology|June 13, 2012
SMARCB1/INI1 inactivation in renal medullary carcinomaJulien Calderaro, Julien Moroch, Gaelle Pierron, et al.
World Journal of Urology|January 2, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic reviewYanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié, et al.
The Journal of Pathology|January 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesisJacqueline Fontugne, Jennifer Wong, Luc Cabel, et al.
Pageof 21

Showing results (111-120 of 208) with videos related to

Sort By:
Pageof 21
BJU International|January 7, 2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomyXavier Durand, Evanguelos Xylinas, Camelia Radulescu, et al.
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
Journal of the National Cancer Institute|December 22, 2010
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionCéline Vallot, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
The Prostate|April 26, 2006
Protocadherin-PC promotes androgen-independent prostate cancer cell growthStephane Terry, Luis Queires, Sixtina Gil-Diez-de-Medina, et al.
Clinical Genitourinary Cancer|August 25, 2016
Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary CohortDamien Pouessel, Sylvie Bastuji-Garin, Nadine Houédé, et al.
BJU International|December 3, 2022
A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancerYann Neuzillet, Priscilla Leon, Thomas Seisen, et al.
Urology|November 16, 2005
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcomeMark A Rubin, Yves Allory, Vincent Molinié, et al.
Histopathology|June 13, 2012
SMARCB1/INI1 inactivation in renal medullary carcinomaJulien Calderaro, Julien Moroch, Gaelle Pierron, et al.
World Journal of Urology|January 2, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic reviewYanish Soorojebally, Yann Neuzillet, Mathieu Roumiguié, et al.
The Journal of Pathology|January 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesisJacqueline Fontugne, Jennifer Wong, Luc Cabel, et al.
Pageof 21